Medical Cosmetic Manufacture IMEIK Goes Public, Raising CNY 3.57 Bn
IMEIK Technology Development Co, Ltd is an enterprise focusing on Hyaluronic Acid's research and development manufacture and sales (known as 'HA'). The company landed on China's Growth Enterprises Market (GEM) and issued 30.2 million shares at CNY 118.27 per share, accounting for 25.12% of the total 120 million shares. IMEIK Tech raised CNY 3.57 billion and CNY 3.44 billion for net proceeds.
The company has primarily anchored on HA-based products and other relevant medical cosmetology products. IMEIK's two peers: Bloomage (688363:SH) and Haohai Biological (688366:SH) – Bloomage builds a vertically-extending industry chain Haohai Biological covers a broad spectrum of the downstream segment. Moreover, IMEIK's most revenue growth has come from only one core product, 'Haiti.'
Compare to its peers, IMEK has not built a substantial technology moat but still very competitive in the market and is expected to grow at a middle-term period.
This text is a result of machine translation.
Related companies：
Briefing Yesterday 11:57 AM
· Healthcare
Triarm therapeutics completed a round of financing of US $60 million
Briefing Sep 24, 2021 11:28 AM
· Healthcare
The medical and American plate rose sharply
In depth
Research
Technology, Consumer Staples, HealthcareWIA2020 | Rising Tech Stars 2020: Global & China's 100
Dec 09, 2020 09:57 AM
Dec 09, 2020 09:39 AM
Aug 09, 2020 12:23 AM
Research
Industrials, Financials, AutomotiveTech for Global, Globalization Footprints of the Established and the New
May 29, 2020 08:30 PM
Briefing Jul 23, 2021 10:13 AM
· Healthcare
Pharmaceutical and biological stocks fell sharply in early trading
Insight
Healthcare
Sinopharm COVID Vaccine Receives WHO Emergency Use Certification
The Sinopharm Group’s COVID Vaccine is the sixth vaccine to receive safety, efficacy and quality verification from the World Health Organization (WHO). It is the first vaccine from a non-Western country to receive WHO certification.
May 11, 2021 03:35 AM
Healthcare
Yunnan Baiyao's Revenue Rises 33%; Net Profit Falls 40% in 1Q 2021
On April 27, Yunnan Baiyao released a report for the first quarter of 2021 showing that the company's total operating revenue for the first quarter was 10.33 billion yuan, up 33.4% year-on-year; its operating profit was 880 million yuan, down 41.8% year-on-year; its net profit attributable to shareholders of the listed company was 760 million yuan.
Apr 30, 2021 02:07 AM
Healthcare
WIM2020: Insights on the Post-pandemic Outlook for the Healthcare Industry
The curtain came down on Dec 10 on the 'Healthtech Industry and COVID-19 Pandemic' Chapter at WIM 2020. Healthtech entrepreneurs and investors gathered to share insights on the outlook for the healthcare industry, covering topics like vaccination, AI healthcare, intelligent hardware, medical appliances and IVD.
Jan 07, 2021 02:10 PM
Briefing Jul 06, 2021 10:41 AM
· Healthcare
Yimei concept stocks all weakened, Aoyuan Meigu closed down
Briefing Jul 01, 2021 09:42 PM
· Healthcare
Tebao Bio: net profit is expected to increase by 50.18% - 58.76% year on year in the first half of the year
Briefing Jun 24, 2021 10:13 AM
· Healthcare
IC insights: the global MEMS market will reach a record 15.9 billion US dollars
See more
Read next
Insight
In depth
Consumer Staples
Dada Nexus Beats Q2 2021 Earnings Estimates, Growth Accelerates
Sep 18, 2021 12:01 AM
EqualOcean is an information service provider and investment research company that aims to become a global platform for industrial innovation. Founded in February 2014 and headquartered in Beijing, with a client network covering over 50 countries, the firm provides comprehensive professional services, including industry research, investment analysis, innovation consulting, data products, corporate branding and international strategy.